Signed in
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
We are developing a novel class of molecules that have MDMA-like activity with better safety profiles, reduced side effects (“the come down”), and increased clinical value. DESCI already in the same room with us.